Impact of China's public hospital reform on healthcare expenditures and utilization: A case study in ZJ province

PLoS ONE

Volumn 10, Issue 11, 2015, Pages

  Zhang, Hao ^a   Hu, Huimei ^b   Wu, Christina ^a   Yu, Hai ^a   Dong, Hengjin ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b PEOPLE S HOSPITAL OF HANGZHOU MEDICAL COLLEGE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

PRESCRIPTION DRUG;

ARTICLE; CHINA; CONTROLLED STUDY; DRUG COST; DRUG UTILIZATION; HEALTH CARE COST; HEALTH CARE NEED; HEALTH CARE POLICY; HEALTH CARE UTILIZATION; HOSPITAL CARE; HUMAN; MEDICAL DECISION MAKING; OUTPATIENT CARE; PROFIT; QUESTIONNAIRE; RETROSPECTIVE STUDY; AMBULATORY CARE; DECISION MAKING; ECONOMICS; HEALTH CARE DELIVERY; HEALTH CARE PLANNING; HOSPITAL; ORGANIZATION AND MANAGEMENT; PRESCRIPTION; PUBLIC HOSPITAL; TREATMENT OUTCOME;

AMBULATORY CARE; CHINA; DECISION MAKING; DRUG COSTS; DRUG PRESCRIPTIONS; HEALTH CARE REFORM; HEALTH EXPENDITURES; HEALTH POLICY; HEALTH RESOURCES; HEALTH SERVICES ACCESSIBILITY; HOSPITALS; HOSPITALS, PUBLIC; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84958025808     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0143130     Document Type: Article

References (70)

1. World Health Organization. The world health report 2008: primary health care: now more than ever. World Health Organization; 2008.
2. Ministry of Health. China's health statistics yearbook 2012. Beijing: China Statistics Press; 2013.
3. National Statistical Bureau. China's statistic year book 2012. Beijing: China Statistics Press; 2013.
4. Ministry of Health. China's health statistical digest 2012. 2013. Beijing: China Statistics Press; 2013.
5. OECD Library. Health at a glance: Europe 2010. 2010; Available: http://www.oecd-ilibrary.org/socialissues-migration-health/health-at-a-glance-europe-2010-health-glance-2010-en.
6. Jiang M, Yang S, Yan K, Liu J, Zhao J, Fang Y. Measuring Access to medicines: A survey of prices, availability and affordability in Shaanxi Province of China. PLoS One. 2013; 8(8): e70836. doi: 10.1371/journal.pone.0070836 PMID: 23936471
7. Meng Q, Cheng G, Silver L, Sun X, Rehnberg C, Tomson G. The impact of China's retail drug price control policy on hospital expenditures: a case study in two Shandong hospitals. Health Policy and Planning. 2015; 20(3): 185-196.
8. Li Y, Wu Q, Xu L, Legge D, Hao Y, Gao L, et al. Factors affecting catastrophic health expenditure and impoverishment from medical expenses in China: policy implications of universal health insurance. Bulletin of the World Health Organization. 2012; 90(9): 664-671. doi: 10.2471/BLT.12.102178 PMID: 22984311
9. Song Y, Bian Y, Petzold M, Li L, Yin A. Effects of the National Essential Medicine System in reducing drug prices: an empirical study in four Chinese provinces. Journal of pharmaceutical policy and practice. 2014; 7(1): 12. doi: 10.1186/2052-3211-7-12 PMID: 25317336
10. Currie J, Lin W, Meng J. Addressing antibiotic abuse in China: An experimental audit study. Journal of Development Economics, 2014, 110: 39-51.
11. Currie J, Lin W, Zhang W. Patient knowledge and antibiotic abuse: Evidence from an audit study in China. Journal of health economics. 2011; 30(5): 933-949. doi: 10.1016/j.jhealeco.2011.05.009 PMID: 21733587
12. Hu S, Liu X, Peng Y. Assessment of antibiotic prescription in hospitalized patients at a Chinese University Hospital. Journal of Infection. 2003; 46(3): 161-163. PMID: 12643864
13. Zhang W, Shen X, Wang Y, Chen Y, Huang M, Zeng Q, et al. Outpatient antibiotic use and assessment of antibiotic guidelines in Chinese children's hospitals. European Journal of Clinical Pharmacology. 2008; 64(821): 821-828.
14. China's State Food and Drug Administration. The annual report of national adverse drug reaction monitoring 2013. 2014; Available: http://www.sda.gov.cn/WS01/CL0078/99794.html.
15. Folland S, Goodman AC, Stano M. The economics of health and health Care. New Jersey: Prentice Hall; 2007.
16. Wolinsky A. Competition in a market for informed experts' services. The RAND Journal of Economics. 1993; 380-398.
17. Rizzo JA, Blumenthal D. Is the target income hypothesis an economic heresy? Medical care research and review. 1996; 53(3): 243-66. PMID: 10159929
18. Culyer A, Newhouse J. Handbook of health economics. Newhouse; 2012.
19. Fujisawa R, Lafortune G. The remuneration of general practitioners and specialists in 14 OECD counties: What are the factors influencing variations across countries. 2008; Available: http://www.oecdilibrary.org/social-issues-migration-health/the-remuneration-of-general-practitioners-and-specialistsin- 14-oecd-countries-228632341330
20. Ding XY. Physician compensation report 2012-2013, China Health Human Resources 2014; 5: 74-75.
21. Medscape. Physician compensation Report 2013. 2014; Available: http://www.medscape.com/features/slideshow/compensation/2013/public.
22. Ran LM, Luo KJ, Wu YC, Yao L, Fen YM. An analysis of China's physician salary payment system. Journal of Huazhong University of Science and Technology. 2013; 33: 309-314. doi: 10.1007/s11596-013-1116-9 PMID: 23592149
23. Zhao T. Workload of primary care physicians in rural China: evidences from three provinces. Economic Review. 2014; 1: 12-24.
24. Delattre E, Dormont B. Fixed fees and physician-induced demand: A panel data study on French physicians. Health Economics. 2013; 12(9): 741-754.
25. Horwitz JR. Making profits and providing care: Comparing nonprofit, for-profit, and government hospitals. Health Affairs. 2005; 24(3): 790-801. PMID: 15886174
26. LI L, Jang Y, Chen QL. A Review of China's health care reform after the reform and open policy in 1978. Chinese Health Economics. 2008; 27(2): 5-9.
27. Zhang YH. On supplying and financing of rural public hygienic service. International Medicine and Health Guidance News. 2005; 13: 18-26.
28. Dong HJ, Bogg L, Rehnberg C, Vinod D. Drug policy in China: pharmaceutical distribution in rural. Social Science and Medicine. 1999; 48: 777-786. PMID: 10190640
29. Zhang J, Zhang YP, Lan X. On the impact of abolishing drug price addition to public hospitals. Chinese Journal of Hospital Administration. 2009; 25(8): 521-526.
30. Zhang Y, Chen YW. Drawbacks of the second bargain of drug centralized bidding procurement and the solutions. Chinese Pharmaceutical Affairs. 2013; 3: 255-257.
31. Zhang J, Zhang YP, Lan X. On the impact of abolishing drug price addition to public hospitals. Chinese Journal of Hospital Administration. 2009; 25(8): 521-526.
32. Fan YL, Liu TF, Yang XF, Yu PM. The problems of second bargaining in bidding of medicine and solutions to issue. China Journal of Pharmaceutical Economics. 2011; 5: 18-21.
33. Hua XY, Gao T, Tian LL, Wang PZ, Xie Z, Jian WY, et al. Effect of income system on physicians' behaviors in public hospitals: a case study of a level tertiary class hospital in Beijing. Medicine and Philosophy. 2014; 35(498): 36-37.
34. Wang HJ. Problem and countermeasure of award distribution in part hospitals. China Journal of Modern Medicine. 2012; 12(21): 99-101.
35. Yang J. Serve the people: understanding ideology and professional ethics of medicine in China. Health Care Analysis. 2010; 18(3): 294-309. doi: 10.1007/s10728-009-0127-y PMID: 19787458
36. Yip W, Hsiao W, Chen W, Hu S, Ma J, Maynard A. The Chinese health system at a crossroads. Health Affairs. 2008; 27(2): 460-468. doi: 10.1377/hlthaff.27.2.460 PMID: 18332503
37. Liu X, Liu Y, Chen N. The Chinese experience of hospital price regulation. Health Policy and Planning. 2000; 15(2): 157-163. PMID: 10837038
38. Meng YL, Zheng ZY. Measurement and analysis of hospital price distortion. Chinese Health Resources. 2003; 6(5): 225-229.
39. Ramesh M, Wu X. Health policy reform in China: lessons from Asia. Social Science and Medicine. 2009; 68(12): 2256-2262. doi: 10.1016/j.socscimed.2009.03.038 PMID: 19419809
40. World Health Organization. The world health report 2000: health systems: improving performance. World Health Organization; 2000.
41. Central Committee of Communist Party of China. Opinions of the Communist Party of China Central Committee and the State Council on deepening the health care system reform, 2009.
42. Chen Z. Launch of the health-care reform plan in China. 2009; 373(9672): 1322-1324. doi: 10.1016/S0140-6736(09)60753-4 PMID: 19376436
43. Zhang X, Chen LW, Mueller K, Yu Q, Liu J, Ge L. Tracking the effectiveness of health care reform in China: a case study of community health centers in a district of Beijing. Health Policy. 2011; 100: 181-188. doi: 10.1016/j.healthpol.2010.10.003 PMID: 21040995
44. Yip W, Hsiao W, Chen W. Early appraisal of China's huge and complex health-care reforms. The Lancet. 2012; 379(9818): 833-842.
45. Ye CY, Duan SN, Wu Y, Hu HM, Liu XF, You H. A preliminary analysis of the effect of the new rural cooperative medical scheme on inpatient care at a county hospital. BMC health services research. 2013; 13(1): 519.
46. The Government of Zhejiang Province. Guidance on trial reform of public hospitals in Zhejiang province, 2009.
47. The Ministry of health and other five Ministries. Guidance on the pilot reform of public hospitals, 2010.
48. The Government of Zhejiang Province. The general situation of Zhejiang Province. 2014; Available: http://www.zhejiang.gov.cn/.
49. The Government of Zhejiang Province. Zhejiang Province's health statistics yearbook 2013. 2014; Beijing: China Statistics Press; 2014.
50. WHO. Essential medicines and health products information. 2003; Available: http://apps.who.int/medicinedocs/en/d/Js4876e/7.html.
51. The people's Government of Zhejiang Province. Statistical bulletin 2012. 2013; Available: http://www.zj.stats.gov.cn/tjgb/gmjjshfzgb/201402/t20140225-122163.html
52. The people's Government of Zhejiang Province. Statistical bulletin 2013. 2014; Available: http://www.zj.stats.gov.cn/tjgb/gmjjshfzgb/201502/t20150227-153394.html.
53. Ellis PD. The Essential Guide to Effect Sizes: An introduction to statistical power, Meta-analysis and the interpretation of research results. United Kingdom: Cambridge University Press; 2010.
54. Mao ZZ, Jiang JL. Estimating quantity of induced demand for medical services in China. Chinese Health Economics. 2006; 25:65-70.
55. Hu HM, Wu Y, Ye CY, Duan SN, Wang LH, Ma WH. preliminary evaluation of county-level public hospitals reform. Chinese Journal of Hospital Administration. 2013; 29(5): 329-335.
56. Li XW. Discussing the reform of non-profit-drug on medical services of county state-owned hospitals in group-based payment system. Chinese Health Service Management. 2014; 5(311): 335-338.
57. Shigeoka H, Fushimi K. Supplier-induced demand for newborn treatment: Evidence from Japan. Journal of health economics. 2014; 35: 162-178. doi: 10.1016/j.jhealeco.2014.03.003 PMID: 24709038
58. Grytten J, Sørensen R. Type of contract and supplier-induced demand for primary physicians in Norway. Journal of health economics. 2001; 20(3): 379-393. PMID: 11373837
59. Lakdawalla D, Sood N. Innovation and the welfare effects of public drug insurance. Journal of public economics. 2009; 93(3): 541-548.
60. Health Zhejiang on line. The government subsidies for Residents Basic Health has jumped to 400 RMB yuan per capita in Zhejiang Province. 2015; Available: http://health.zjol.com.cn/system/2015/01/15/020464046.shtml.
61. Kingma M. Can financial incentive influence medical practice? Human Resources Development Journal. 1992; 2: 1-12.
62. Boyd CM, Darer J, Boult C, Fried LP, Boult L, Boult L, et al. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. Journal of the American Medical Association. 2005; 294(6): 716-724. PMID: 16091574
63. Hu S, Tang S, Liu Y, Zhao Y, Escobar ML, Ferranti DD. Reform of how health care is paid for in China: challenges and opportunities. The Lancet. 2008; 372(9652): 1846-1853.
64. Hu H. Study on the medical market in rural China. Population and Development. 2008; 3:12-20.
65. Huang CR Liang HC, Chen JH. The current status and development of non-government medical institutions in China. Chinese Health Economics. 2004; 23(1): 57-61.
66. Chow GC. An economic analysis of health care in China. Princeton University; 2006
67. Allard M, Cremer H, Marchand M. Incentive contracts and the compensation of health care providers. Institut d'économie publique; 2002.
68. Beauchamp TL. Principles of biomedical ethics. Oxford university press; 2001.
69. Burgers JS, Grol R, Klazina NS, Mäkelä M, Zaat J. Towards evidence-based clinical practice: an international survey of 18 clinical guideline programs. International Journal for Quality in Health Care. 2003; 15(1): 31-45. PMID: 12630799
70. Liao RM, Xu HB, Sun B, Cheng G, Liu GL. Analysis of medication used in Shanghai sample hospitals from 2009 to 2011. World Clinical Drugs. 2013; 34(6): 347-353.